Cargando…

Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study

AIM: Cirrhosis is a leading cause of death worldwide, yet there are no well‐established risk stratifying tools for lethal complications, including hepatocellular carcinoma (HCC). Patients with liver cirrhosis undergo routine endoscopic surveillance, providing ready access to duodenal aspirate sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Jonathan P., Dong, Tien S., Agopian, Vatche, Lagishetty, Venu, Sundaram, Vinay, Noureddin, Mazen, Ayoub, Walid S., Durazo, Francisco, Benhammou, Jihane, Enayati, Pedram, Elashoff, David, Goodman, Marc T., Pisegna, Joseph, Hussain, Shehnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334634/
https://www.ncbi.nlm.nih.gov/pubmed/29923681
http://dx.doi.org/10.1111/hepr.13207
_version_ 1783387760773562368
author Jacobs, Jonathan P.
Dong, Tien S.
Agopian, Vatche
Lagishetty, Venu
Sundaram, Vinay
Noureddin, Mazen
Ayoub, Walid S.
Durazo, Francisco
Benhammou, Jihane
Enayati, Pedram
Elashoff, David
Goodman, Marc T.
Pisegna, Joseph
Hussain, Shehnaz
author_facet Jacobs, Jonathan P.
Dong, Tien S.
Agopian, Vatche
Lagishetty, Venu
Sundaram, Vinay
Noureddin, Mazen
Ayoub, Walid S.
Durazo, Francisco
Benhammou, Jihane
Enayati, Pedram
Elashoff, David
Goodman, Marc T.
Pisegna, Joseph
Hussain, Shehnaz
author_sort Jacobs, Jonathan P.
collection PubMed
description AIM: Cirrhosis is a leading cause of death worldwide, yet there are no well‐established risk stratifying tools for lethal complications, including hepatocellular carcinoma (HCC). Patients with liver cirrhosis undergo routine endoscopic surveillance, providing ready access to duodenal aspirate samples that could be a source for identifying novel biomarkers. The aim of this study was to characterize the microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis to assess the feasibility of developing biomarkers for HCC risk stratification. METHODS: Thirty patients with liver cirrhosis were enrolled in the Microbiome, Microbial Markers, and Liver Disease study between May 2015 and March 2017. Detailed clinical and epidemiological data were collected at baseline and at 6‐monthly follow‐up visits. Duodenal aspirate fluid was collected at baseline for microbial characterization using 16S ribosomal RNA sequencing and bile acid quantification using mass spectroscopy. RESULTS: Alcohol‐related cirrhosis was associated with reductions in the Bacteroidetes phylum, particularly Prevotella (13‐fold reduction), and expansion of Staphylococcus (13‐fold increase), compared to hepatitis C virus‐related cirrhosis. Participants with hepatic encephalopathy (HE) had less microbial diversity compared to patients without HE (P < 0.05), and were characterized by expansion of Mycobacterium (45‐fold increase) and Gram‐positive cocci including Granulicatella (3.1‐fold increase), unclassified Planococcaceae (3.3‐fold increase), and unclassified Streptococcaceae (4.5‐fold increase). Non‐Hispanic White patients had reduced microbial richness (P < 0.01) and diversity (P < 0.05), and increased levels of conjugated ursodeoxycholic acid (glycoursodeoxycholic acid and tauroursodeoxycholic acid, P < 0.05) compared to Hispanic patients. CONCLUSION: Microbial profiles of duodenal aspirates differed by cirrhosis etiology, HE, and Hispanic ethnicity.
format Online
Article
Text
id pubmed-6334634
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63346342019-01-23 Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study Jacobs, Jonathan P. Dong, Tien S. Agopian, Vatche Lagishetty, Venu Sundaram, Vinay Noureddin, Mazen Ayoub, Walid S. Durazo, Francisco Benhammou, Jihane Enayati, Pedram Elashoff, David Goodman, Marc T. Pisegna, Joseph Hussain, Shehnaz Hepatol Res Original Articles AIM: Cirrhosis is a leading cause of death worldwide, yet there are no well‐established risk stratifying tools for lethal complications, including hepatocellular carcinoma (HCC). Patients with liver cirrhosis undergo routine endoscopic surveillance, providing ready access to duodenal aspirate samples that could be a source for identifying novel biomarkers. The aim of this study was to characterize the microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis to assess the feasibility of developing biomarkers for HCC risk stratification. METHODS: Thirty patients with liver cirrhosis were enrolled in the Microbiome, Microbial Markers, and Liver Disease study between May 2015 and March 2017. Detailed clinical and epidemiological data were collected at baseline and at 6‐monthly follow‐up visits. Duodenal aspirate fluid was collected at baseline for microbial characterization using 16S ribosomal RNA sequencing and bile acid quantification using mass spectroscopy. RESULTS: Alcohol‐related cirrhosis was associated with reductions in the Bacteroidetes phylum, particularly Prevotella (13‐fold reduction), and expansion of Staphylococcus (13‐fold increase), compared to hepatitis C virus‐related cirrhosis. Participants with hepatic encephalopathy (HE) had less microbial diversity compared to patients without HE (P < 0.05), and were characterized by expansion of Mycobacterium (45‐fold increase) and Gram‐positive cocci including Granulicatella (3.1‐fold increase), unclassified Planococcaceae (3.3‐fold increase), and unclassified Streptococcaceae (4.5‐fold increase). Non‐Hispanic White patients had reduced microbial richness (P < 0.01) and diversity (P < 0.05), and increased levels of conjugated ursodeoxycholic acid (glycoursodeoxycholic acid and tauroursodeoxycholic acid, P < 0.05) compared to Hispanic patients. CONCLUSION: Microbial profiles of duodenal aspirates differed by cirrhosis etiology, HE, and Hispanic ethnicity. John Wiley and Sons Inc. 2018-07-30 2018-12 /pmc/articles/PMC6334634/ /pubmed/29923681 http://dx.doi.org/10.1111/hepr.13207 Text en © 2018 The Authors. Hepatology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Hepatology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Jacobs, Jonathan P.
Dong, Tien S.
Agopian, Vatche
Lagishetty, Venu
Sundaram, Vinay
Noureddin, Mazen
Ayoub, Walid S.
Durazo, Francisco
Benhammou, Jihane
Enayati, Pedram
Elashoff, David
Goodman, Marc T.
Pisegna, Joseph
Hussain, Shehnaz
Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title_full Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title_fullStr Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title_full_unstemmed Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title_short Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
title_sort microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: the microbiome, microbial markers and liver disease study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334634/
https://www.ncbi.nlm.nih.gov/pubmed/29923681
http://dx.doi.org/10.1111/hepr.13207
work_keys_str_mv AT jacobsjonathanp microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT dongtiens microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT agopianvatche microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT lagishettyvenu microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT sundaramvinay microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT noureddinmazen microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT ayoubwalids microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT durazofrancisco microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT benhammoujihane microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT enayatipedram microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT elashoffdavid microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT goodmanmarct microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT pisegnajoseph microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy
AT hussainshehnaz microbiomeandbileacidprofilesinduodenalaspiratesfrompatientswithlivercirrhosisthemicrobiomemicrobialmarkersandliverdiseasestudy